Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with ...

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that ...

Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...

The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...

DelveInsight's Transmucosal Drugs Market Insights report provides the current and forecast market analysis, individual ...

Pancreatic cancer, one of the most aggressive and lethal types of cancer, continues to present significant challenges in both its detection and treatment. The lack of early detection tools, coupled ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Delhi Election Result Key Highlights: The Delhi Election Result 2025 were declared on Saturday by the Election Commission of India (ECI), marking a crucial moment in Delhi's political landscape as ...

Competitive pressures remain as a major concern for Neurocrine, given the emergence of similar products from companies like Teva Pharmaceuticals (NYSE:TEVA). To address this, the company emphasizes ...

Petah Tikvah, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a leading innovator in transportation safety technology, today announced the award of a new ...

(Continued from "Pharma news highlights ... Teva Pharmaceuticals has temporarily frozen plans to fire those workers while talks are held simultaneously with the government and key labor unions.